New credit facility at emergence
Company: Core Scientific
The claim, verbatim
The company says a new credit facility, together with projected operating cash flow, gives it sufficient liquidity to emerge and carry out its multi-year growth plan.
Source (primary)
core-scientific 8-K exhibit (d735123dex993.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-11-13)Live source ↗
Quote: “With sufficient liquidity from a new credit facility and projected operating cash flow, the Company is set to emerge and continue executing its multi-year growth plan”
How we checked this
Checked on November 14, 2026. The cited source supports every part of this claim.
The release says the new credit facility and projected operating cash flow provide sufficient liquidity for the company to emerge and continue its multi-year growth plan.
Confirmed in the source:
- Core Scientific has a new credit facility at emergence
- The company says the new credit facility and projected operating cash flow provide sufficient liquidity
- The company says this liquidity lets it emerge and continue executing its multi-year growth plan
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000119312524014941/d735123dex993.htm) in full (10,312 characters, retrieved November 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (d735123dex993.htm)
Quote: “With sufficient liquidity from a new credit facility and projected operating cash flow, the Company is set to emerge and continue executing its multi-year growth plan”